-
Mashup Score: 41
Pembrolizumab plus chemoradiotherapy did not significantly improve event-free survival compared with chemoradiotherapy alone in a molecularly unselected, locally advanced HNSCC population. No new safety signals were seen. Locally advanced HNSCC remains a challenging disease that requires better treatment approaches.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2When leukaemia masquerades: the hidden syphilis diagnosis - 1 day(s) ago
A 61-year-old man with chronic lymphocytic leukaemia maintained on oral venetoclax 400 mg daily presented to the emergency department with oral lesions, worsening lymphadenopathy, and fevers. CT showed multiple enlarged submandibular and submental lymph nodes, and fine needle aspiration with flow cytometry demonstrated a predominantly lymphocytic population positive for CD19 with co-expression of CD5 and variable CD23 expression and lambda light chain restriction consistent with chronic lymphocytic leukaemia involving a lymph node.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study - 4 day(s) ago
Total national health expenditure is associated with geographical inequalities in lymphoid malignancy prognosis. Policy decisions on allocating economic resources and implementing evidence-based models of care are needed to reduce these differences.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 43
The purpose of this European Society for Radiotherapy and Oncology (ESTRO) project, endorsed by the European Association of Urology, is to explore expert opinion on the management of patients with oligometastatic and oligoprogressive renal cell carcinoma by means of stereotactic ablative radiotherapy (SABR) on extracranial metastases, with the aim of developing consensus recommendations for patient selection, treatment doses, and concurrent systemic therapy. A questionnaire on SABR in oligometastatic renal cell carcinoma was prepared by a core group and reviewed by a panel of ten prominent experts in the field.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 23
Cabozantinib shows promising activity in patients with MPPGs.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial - 4 day(s) ago
Cabozantinib in advanced adrenocortical carcinoma showed promising efficacy with a manageable and anticipated safety profile. Further prospective studies with cabozantinib alone and in combination with immune checkpoint therapy are ongoing.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
Funding is urgently needed to support end-of-life care for patients in hospices across the UK, according to general consensus during a parliamentary debate in the UK House of Commons.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Facing close competition for re-election and concerted pushback from the tobacco industry and its allies, the US Government administration of President Joe Biden has delayed a long-anticipated federal ban on menthol cigarettes, officials announced on April 26, 2024. Public health and civil rights organisations, such as the National Association for the Advancement of Colored People (NAACP), condemned the decision, stating any delay will cost lives and prioritises politics over cancer prevention and public health.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
Funding is urgently needed to support end-of-life care for patients in hospices across the UK, according to general consensus during a parliamentary debate in the UK House of Commons.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 23
Cabozantinib shows promising activity in patients with MPPGs.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
ICYMI: KEYNOTE-412: Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, phase 3 trial https://t.co/cYOIX0XjN7 #headandneckcancer